Effect of AT1 angiotensin II receptor antagonists on the sympathetic response to a cold pressor test in healthy volunteers

American Journal of Therapeutics

Volumn 14, Issue 2, 2007, Pages 183-188

  Israel, Anita ^a,b,c   Zavala, Lida Esther ^b   Cierco, Maria ^b   Gutierrez, Antonio ^c   Garrido, Maria Del Rosario ^a  

^a UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^b Universidad Nacional Experimental Francisco de Miranda   (Venezuela)

^c NONE

Author keywords

Cold pressor test; Eprosartan; Losartan; Valsartan

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN II; EPROSARTAN; LOSARTAN; LOSARTAN POTASSIUM; PLACEBO; VALSARTAN;

ADULT; ARTERIAL PRESSURE; BLOOD PRESSURE; CLINICAL TRIAL; COLD PRESSOR TEST; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HEART HEMODYNAMICS; HEART RATE; HEMODYNAMIC PARAMETERS; HUMAN; MALE; MEAN ARTERIAL PRESSURE; NORMAL HUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE; SYMPATHETIC TONE; SYSTOLIC BLOOD PRESSURE;

ACRYLATES; ADOLESCENT; ADULT; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; BLOOD PRESSURE; COLD; DOUBLE-BLIND METHOD; FEMALE; HEART RATE; HUMANS; IMIDAZOLES; LOSARTAN; MALE; MIDDLE AGED; SYMPATHETIC NERVOUS SYSTEM; TETRAZOLES; THIOPHENES; VALINE;

EID: 34247096519     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mjt.0000245235.88942.20     Document Type: Conference Paper

References (41)

1. Jindra A Jr, Kvetnansky R. Stress-induced activation of inactive renin: molecular weight aspects. J Biol Chem. 1982;257:5997-5999.
2. Ganong WF, Barbieri C. Neuroendocrine components in the regulation of rennin secretion. In: Ganong WF, Martini L, eds. Frontiers in Neuroendocrinology. New York, NY: Raven Press; 1982:231-262.
3. Catt KJ, Mendelshon FAO, Millan MA, et al. The role of angiotensin II receptors in vascular regulation. J Cardiovasc Pharmacol. 1984;6(Suppl 4):5575-5586.
4. Catt KJ, Wyann PC, Millan MA, et al. Brain receptors for angiotensin II and corticotropin releasing factor. In: Ganong WF, Martini L, eds. Frontiers in Neuroendocrinology. New York, NY: Raven Press; 1986:225-253.
5. Saavedra JM. Brain and pituitary angiotensin. Endocr Rev. 1992;13:329-380.
6. Aguilera G, Kiss A, Luo X. Increased expression of type 1 angiotensin II receptors in the hypothalamic paraventricular nucleus following stress and glucocorticoid administration. J Neuroendocrinol. 1995;7:775-783.
7. Castrén E, Saavedra JM. Angiotensin II receptors in the paraventricular nucleus, subfornical organ and pituitary gland of hypophysectomized, adrenolectomized and vasopressin-deficient rats. Proc Natl Acad Sci USA. 1989;86:725-729.
8. Dendorfer A, Raasch W, Tempel K, et al. Interactions between the renin-angiotensin system (RAS) and the sympathetic system. Basic Res Cardiol. 1998;93(Suppl):24-29.
9. Xu L, Brooks VL. ANG II chronically supports renal and lumbar sympathetic activity in sodium-deprived, conscious rats. Am J Physiol (Heart Circ Physiol 40). 1996;271:H2591-H2598.
10. 1 receptor in the cardiovascular response to footshock. Eur J Pharmacol. 1994;251:103-106.
11. Mendelsohn FAO, Doyle AE, Gray GW. Lack of response of sympathetic nervous system to angiotensin infusion. Lancet. 1990;1:492-493.
12. Reid IA. Interactions between ANG II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure. Am J Physiol (Endocrinol Metab 25). 1992;262:E763-E778.
13. Brunner HR, Nussberger J, Waeber B. Angiotensin II blockade compared with other pharmacological methods of inhibiting the renin-angiotensin system. J Hypertens. 1993;11(Suppl 3):553-558.
14. Beaulieu M, Lacourciere Y, Cleroux J. Unchanged neurogenic vasoconstrictor response after exercise during angiotensin converting enzyme inhibition with fosinopril. Am J Hypertens. 1994;7:763-766.
15. McGrath BP, Arnold LF. Enalapril reduces the catecholamine response to exercise in patients with heart failure. Eur J Clin Pharmacol. 1986;30:485-487.
16. Minatoguchi S, Ito H, Koshiji M, et al. Enalapril decreases plasma noradrenaline levels during the cold pressor test in human hypertensives. Clin Exp Pharmacol Physiol. 1992;19:279-282.
17. 1 receptor blockade and the sympathoadrenal response to insulin-induced hypoglycemia in humans. Am J Physiol (Endocrinol Metab 35). 1997;272:E415-E421.
18. Rodriguez-García JL, Paule A, Dominguez J, et al. Effect of the angiotensin II antagonist losartan on endothelin-1 and norepinephrine plasma levels during cold pressor test in patients with chronic heart failure. Int J Cardiol. 1999;70:293-301.
19. Hines EA, Brown GE. The cold pressor test for measuring the reactivity of the blood pressure: data concerning 571 normal and hypertensive subjects. Am Heart J. 1936:11:1-9.
20. Fagius J, Karhuvaara S. Sympathetic activity and blood pressure increases with bladder distension in humans. Hypertension. 1989;14:511-517.
21. Victor RG, Leimbach WN Jr, Seals DR, et al. Effects of the cold pressor test on muscle sympathetic nerve activity in humans. Hypertension. 1987;9:429-436.
22. Fyhrquist F, Saijonmaa O, Metsarinne K, et al. Raised plasma endothelin-1 concentration following cold pressor test. Biochem Biophys Res Commun. 1990;169:217-221.
23. Rostrup M, Smith G, Bjornstad H, et al. Left ventricular mass and cardiovascular reactivity in young men. Hypertension. 1994;23(I Suppl):I168-I171.
24. 3H-norepinephrine in dog cutaneous arteries. Proc Soc Exp Biol Med. 1972;139:216-219.
25. Ferrario CM, Gildenberg PL, McCubbin JW. Cardiovascular effects of angiotensin mediated by central nervous system. Circ Res. 1972;30:257-262.
26. Castrén E, Saavedra JM. Repeated stress increases the density of angiotensin II binding sites in the rat paraventricular nucleus and subfornical organ. Endocrinology. 1988;122:370-372.
27. Saavedra JM, Ando H, Armando I, et al. Brain angiotensin II, an important stress hormone: Regulatory sites and therapeutic opportunities. Ann NY Acad Sci. 2004;1018:76-84.
28. Wong PB, Bernard R, Timmermans PBMWM. Effect of blocking angiotensin II receptor subtype on rat sympathetic nerve function. Hypertension. 1992;19(6 Suppl):663-667.
29. 1 receptor antagonist decreases the hypothalamic-pituitary-adrenal response to isolation stress. Endocrinology. 2001;142:3880-3889.
30. Eliot RS. Stress and the heart: Mechanisms, measurement, and management. Postgrad Med. 1992;92:237-248.
31. Wong PC, Hart SD, Timmermans PBMWM. Effect of angiotensin II antagonism on canine renal sympathetic nerve function. Hypertension. 1991;17:1127-1134.
32. 1-receptor subtype. Br J Pharmacol. 1993;110:761-771.
33. Wong PC, Price WA, Chiu AT, et al. Nonpeptide angiotensin II receptor antagonists. VIII. Characterization of functional antagonism displayed by DuP 753, an orally active antihypertensive agent. J Pharmacol Exp Ther. 1990;252:719-725.
34. Edwards RM, Aiyar N, Ohlstein EH, et al. Pharmacological characterization of the nonpeptide angiotensin II receptor antagonist, SK and F 108566. J Pharmacol Exp Ther. 1992;260:175-181.
35. Brooks DP, Ohlstein EH, Ruffolo RR Jr. Pharmacology of eprosartan, an angiotensin II receptor antagonist: Exploring hypotheses from clinical data. Am Heart J. 1999;138:S246-S251.
36. Yamamoto S, Iwase S, Mano T. Responses of muscle sympathetic nerve activity and cardiac output to the cold pressor test. Jpn J Physiol. 1992;42:239-252.
37. Parati G, Pomidossi G, Ramirez A, et al. Reproducibility of laboratory tests evaluating neural cardiovascular regulation in man. J Hypertens Suppl. 1983;1:88-90.
38. 1 receptor blockade alters aortic nerve activity in hypertension. Hypertension. 1998;31:973-977.
39. Zoppi A, Sudano S, Bosco L, et al. Effects of captopril on cold pressor test responses in normotensive and hypertensive subjects. Am J Med. 1988;84:145-147.
40. Cohn JN, Levine TB, Olivari MT, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984;311:819-823.
41. Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med. 1996;334:1349-1355.